173 related articles for article (PubMed ID: 38557247)
21. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK
Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837
[TBL] [Abstract][Full Text] [Related]
22. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
[TBL] [Abstract][Full Text] [Related]
24. NS7a of SADS-CoV promotes viral infection via inducing apoptosis to suppress type III interferon production.
Wang X; Qiu W; Hu G; Diao X; Li Y; Li Y; Li P; Liu Y; Feng Y; Xue C; Cao Y; Xu Z
J Virol; 2024 May; 98(5):e0031724. PubMed ID: 38624231
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.
Lu M; Chamblee M; Zhang Y; Ye C; Dravid P; Park JG; Mahesh KC; Trivedi S; Murthy S; Sharma H; Cassady C; Chaiwatpongsakorn S; Liang X; Yount JS; Boyaka PN; Peeples ME; Martinez-Sobrido L; Kapoor A; Li J
Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2110105119. PubMed ID: 35994646
[TBL] [Abstract][Full Text] [Related]
26. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
Nambulli S; Escriou N; Rennick LJ; Demers MJ; Tilston-Lunel NL; McElroy AK; Barbeau DJ; Crossland NA; Hoehl RM; Schrauf S; White AG; Borish HJ; Tomko JA; Frye LJ; Scanga CA; Flynn JL; Martin A; Gerke C; Hartman AL; Duprex WP
J Virol; 2024 May; 98(5):e0176223. PubMed ID: 38563762
[TBL] [Abstract][Full Text] [Related]
27. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
[TBL] [Abstract][Full Text] [Related]
28. Establishment of Replication Deficient Vesicular Stomatitis Virus for Studies of PEDV Spike-Mediated Cell Entry and Its Inhibition.
Luo H; Lv L; Yi J; Zhou Y; Liu C
Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630636
[TBL] [Abstract][Full Text] [Related]
29. Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection.
Edwards CE; Yount BL; Graham RL; Leist SR; Hou YJ; Dinnon KH; Sims AC; Swanstrom J; Gully K; Scobey TD; Cooley MR; Currie CG; Randell SH; Baric RS
Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26915-26925. PubMed ID: 33046644
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Immune Response Diversity in Rodents Vaccinated with a Vesicular Stomatitis Virus Vectored COVID-19 Vaccine.
Wang S; Zhang C; Liang B; Wang W; Feng N; Zhao Y; Wang T; Guo Z; Yan F; Yang S; Xia X
Viruses; 2022 May; 14(6):. PubMed ID: 35746599
[TBL] [Abstract][Full Text] [Related]
31. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines.
Whitt MA
J Virol Methods; 2010 Nov; 169(2):365-74. PubMed ID: 20709108
[TBL] [Abstract][Full Text] [Related]
32. Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1.
Ao Z; Wang L; Azizi H; Olukitibi TA; Kobinger G; Yao X
J Virol; 2021 Jul; 95(15):e0236820. PubMed ID: 34011553
[TBL] [Abstract][Full Text] [Related]
33. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
Ikegame S; Siddiquey MNA; Hung CT; Haas G; Brambilla L; Oguntuyo KY; Kowdle S; Chiu HP; Stevens CS; Vilardo AE; Edelstein A; Perandones C; Kamil JP; Lee B
Nat Commun; 2021 Jul; 12(1):4598. PubMed ID: 34312390
[TBL] [Abstract][Full Text] [Related]
34. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S
J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974
[TBL] [Abstract][Full Text] [Related]
35. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
Kato H; Takayama-Ito M; Iizuka-Shiota I; Fukushi S; Posadas-Herrera G; Horiya M; Satoh M; Yoshikawa T; Yamada S; Harada S; Fujii H; Shibamura M; Inagaki T; Morimoto K; Saijo M; Lim CK
PLoS One; 2019; 14(10):e0223684. PubMed ID: 31589656
[TBL] [Abstract][Full Text] [Related]
36. Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins.
Guan H; Wang Y; Perčulija V; Saeed AFUH; Liu Y; Li J; Jan SS; Li Y; Zhu P; Ouyang S
J Virol; 2020 Oct; 94(22):. PubMed ID: 32817223
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a novel bat-HKU2-like swine enteric alphacoronavirus (SeACoV) infection in cultured cells and development of a SeACoV infectious clone.
Yang YL; Liang QZ; Xu SY; Mazing E; Xu GH; Peng L; Qin P; Wang B; Huang YW
Virology; 2019 Oct; 536():110-118. PubMed ID: 31419711
[TBL] [Abstract][Full Text] [Related]
38. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.
Schmidt F; Weisblum Y; Muecksch F; Hoffmann HH; Michailidis E; Lorenzi JCC; Mendoza P; Rutkowska M; Bednarski E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Caskey M; Robbiani DF; Nussenzweig MC; Rice CM; Hatziioannou T; Bieniasz PD
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32692348
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
40. High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission.
Morozov I; Monath TP; Meekins DA; Trujillo JD; Sunwoo SY; Urbaniak K; Kim IJ; Narayanan SK; Indran SV; Ma W; Wilson WC; O'Connor C; Dubey S; Troth SP; Coller BA; Nichols R; Martin BK; Feldmann H; Richt JA
Emerg Microbes Infect; 2021 Dec; 10(1):651-663. PubMed ID: 33719915
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
